Clarification of Optimal Anticoagulation through Genetics (COAG)

ID Number 08-0838

Principal Investigator(s)
Robert J Desnick

Department(s) or Division(s)
Genetics and Genomic Sciences

Research Entity
The Zena and Michael A. Wiener Cardiovascular Institute


The purpose of this study is to find out the best way to start warfarin treatment. This study will test whether doctors can improve the control of blood thinning by using genetic information. This information is thought to improve the safe use of warfarin since choosing the correct warfarin dose is important to prevent blood clots and avoid bleeding.

Contact Information
Dana O. Doheny, MS, CGC
(212) 659-6779

Recruiting Patients: Yes